These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 9109296)
1. Treatment of ocular bacterial infections: an update. Hammond RW; Edmondson W J Am Optom Assoc; 1997 Mar; 68(3):178-87. PubMed ID: 9109296 [TBL] [Abstract][Full Text] [Related]
2. A primer on topical antibiotics for the skin and eyes. Noah S J Drugs Dermatol; 2008 Apr; 7(4):409-15. PubMed ID: 18459527 [TBL] [Abstract][Full Text] [Related]
3. A review of common ophthalmic antibacterial and corticosteroid-antibacterial combination drugs. Thomas RK; Melton NR Optom Clin; 1992; 2(4):45-57. PubMed ID: 1286240 [TBL] [Abstract][Full Text] [Related]
4. Antibacterial agents for ocular therapeutics. Kern TJ Vet Clin North Am Small Anim Pract; 2004 May; 34(3):655-68. PubMed ID: 15110977 [TBL] [Abstract][Full Text] [Related]
5. Ocular bacterial infections: current and future treatment options. Kowalski RP; Dhaliwal DK Expert Rev Anti Infect Ther; 2005 Feb; 3(1):131-9. PubMed ID: 15757463 [TBL] [Abstract][Full Text] [Related]
6. Antibiotic resistance in ocular bacterial pathogens. Sharma S Indian J Med Microbiol; 2011; 29(3):218-22. PubMed ID: 21860100 [TBL] [Abstract][Full Text] [Related]
7. Research review and update: IQUIX (levofloxacin 1.5%). McDonald MB Int Ophthalmol Clin; 2006; 46(4):47-60. PubMed ID: 17060791 [No Abstract] [Full Text] [Related]
8. The microbiology of the eye. Armstrong RA Ophthalmic Physiol Opt; 2000 Nov; 20(6):429-41. PubMed ID: 11127123 [TBL] [Abstract][Full Text] [Related]
10. Current evidence for topical azithromycin 1% ophthalmic solution in the treatment of blepharitis and blepharitis-associated ocular dryness. Veldman P; Colby K Int Ophthalmol Clin; 2011; 51(4):43-52. PubMed ID: 21897139 [No Abstract] [Full Text] [Related]
11. Deposits of topical norfloxacin in the treatment of bacterial keratitis. Castillo A; Benitez del Castillo JM; Toledano N; Diaz-Valle D; Sayagues O; Garcia-Sanchez J Cornea; 1997 Jul; 16(4):420-3. PubMed ID: 9220239 [TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo potency of moxifloxacin and moxifloxacin ophthalmic solution 0.5%, a new topical fluoroquinolone. Stroman DW; Dajcs JJ; Cupp GA; Schlech BA Surv Ophthalmol; 2005 Nov; 50 Suppl 1():S16-31. PubMed ID: 16257308 [TBL] [Abstract][Full Text] [Related]
14. Management of bacterial keratitis: beyond exorcism towards consideration of organism and host factors. O'Brien TP Eye (Lond); 2003 Nov; 17(8):957-74. PubMed ID: 14631403 [No Abstract] [Full Text] [Related]
15. Chemical, biological, and radiological weapons: implications for optometry and public health. Hom GG Optometry; 2003 Feb; 74(2):81-98. PubMed ID: 12585736 [TBL] [Abstract][Full Text] [Related]
18. Irrigation with antibiotic-containing solutions for the prevention and treatment of infections. Falagas ME; Vergidis PI Clin Microbiol Infect; 2005 Nov; 11(11):862-7. PubMed ID: 16216099 [TBL] [Abstract][Full Text] [Related]
19. Ocular manifestations and treatment of syphilis. Kiss S; Damico FM; Young LH Semin Ophthalmol; 2005; 20(3):161-7. PubMed ID: 16282150 [TBL] [Abstract][Full Text] [Related]
20. Infectious keratitis after photorefractive keratectomy in the United States army and navy. Wroblewski KJ; Pasternak JF; Bower KS; Schallhorn SC; Hubickey WJ; Harrison CE; Torres MF; Barnes SD Ophthalmology; 2006 Apr; 113(4):520-5. PubMed ID: 16488012 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]